EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ellagic Acid Enhances RSL3 ‐Induced Ferroptosis by Inhibiting the Nrf2/ HO ‐1 Signaling Pathway in Pancreatic Ductal Adenocarcinoma

Jianhua Bai, Yihe Dai, Chern Ein Oon iD, Pingping Hu, Jia Luo, Jiang Han, Liman Yang, Amirabas Bostani, Zhenhao Fei, Yun Jin iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202602231r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Jianhua Bai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery. The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Scienc…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Famous Doctor Projects of Yunnan Province, Liu Liang Expert Workstation of Yunnan Province, Yunnan health training project of high level talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) exhibits profound therapeutic resistance due to redox adaptation, particularly through Nrf2/HO‐1 pathway activation. Ferroptosis induction via GPX4 inhibitors (e.g., RSL3) is promising but limited by adaptive antioxidant responses. Ellagic acid (EA), a natural polyphenol, may overcome this resistance, yet its role in modulating ferroptosis remains unexplored. In vitro studies used KRAS‐mutant and KRAS wild‐type PDAC cell lines (PANC‐1, BxPC‐3) treated with EA, RSL3, or both. Ferroptosis markers (iron, lipid ROS, MDA, GPX4), viability assays, and pathway analyses (Keap1/Nrf2/HO‐1, p38 MAPK) were evaluated. In vivo, antitumor efficacy was assessed in PANC‐1 xenografts. EA synergized with RSL3, reducing viability in PDAC cells ( p < 0.001) and suppressing tumor growth in vivo ( p < 0.001). Combination therapy amplified ferroptotic markers as increased intracellular iron, MDA, and lipid ROS, versus RSL3 alone, while GPX4 expression decreased. Ferroptosis specificity was confirmed via Fer‐1 rescue. Mechanistically, EA activated p38 MAPK, suppressing Nrf2 nuclear translocation and HO‐1 expression. Keap1 upregulation further enhanced Nrf2 degradation. In vivo, EA + RSL3 downregulated Nrf2/HO‐1 and elevated phospho‐p38 in tumors along with the induction of ferroptosis. EA potentiates RSL3‐induced ferroptosis in PDAC by disrupting the p38/Nrf2/HO‐1 axis and elevating Keap1. This natural compound‐based strategy overcomes redox‐driven resistance, offering a translatable approach for PDAC models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2FerroptosisCarcinoma, Pancreatic DuctalPancreatic NeoplasmsSignal TransductionHeme Oxygenase-1Ellagic AcidMembrane ProteinsHumansAnimalsMiceCell Line, TumorMice, NudeXenograft Model Antitumor AssaysFemaleKelch-Like ECH-Associated Protein 1Carbolines

Stichwörter der Autor:innen

Kelch‐like ECH‐associated protein 1MAP kinase signaling systemdrug synergismoxidative stresspancreatic neoplasms

Substanzen

NF-E2-Related Factor 2Heme Oxygenase-1Ellagic AcidNFE2L2 protein, humanRSL3 compoundHMOX1 protein, humanMembrane ProteinsKelch-Like ECH-Associated Protein 1Carbolines

Autor:innen und Institutionen

  • Department of Hepatopancreatobiliary Surgery. The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
  • Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden, Pulau Pinang, Malaysia.
  • First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
  • Department of Biology, Science & Research Institute, Islamic Azad University, Tehran, Iran.

ORCID-Profile: Chern Ein Oon, Yun Jin

Förderung

  • Famous Doctor Projects of Yunnan Province
  • Liu Liang Expert Workstation of Yunnan Province
  • Yunnan health training project of high level talents

Zitieren

APA

Bai, J., Dai, Y., Ein Oon, C., Hu, P., Luo, J., Han, J., Yang, L., Bostani, A., Fei, Z., & Jin, Y. (2026). Ellagic Acid Enhances RSL3 ‐Induced Ferroptosis by Inhibiting the Nrf2/ HO ‐1 Signaling Pathway in Pancreatic Ductal Adenocarcinoma. The FASEB Journal. https://doi.org/10.1096/fj.202602231r

Vancouver

Bai J, Dai Y, Ein Oon C, Hu P, Luo J, Han J, et al. Ellagic Acid Enhances RSL3 ‐Induced Ferroptosis by Inhibiting the Nrf2/ HO ‐1 Signaling Pathway in Pancreatic Ductal Adenocarcinoma. The FASEB Journal. 2026. doi:10.1096/fj.202602231r

BibTeX
@article{Bai2026,
  author = {Bai, Jianhua and Dai, Yihe and Ein Oon, Chern and Hu, Pingping and Luo, Jia and Han, Jiang and Yang, Liman and Bostani, Amirabas and Fei, Zhenhao and Jin, Yun},
  title = {Ellagic Acid Enhances RSL3 ‐Induced Ferroptosis by Inhibiting the Nrf2/ HO ‐1 Signaling Pathway in Pancreatic Ductal Adenocarcinoma},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202602231r}
}
Kostenlos starten →